Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mediwound Ltd Ord Sh
(NQ:
MDWD
)
16.31
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mediwound Ltd Ord Sh
< Previous
1
2
3
4
5
Next >
Recap: MediWound Q3 Earnings
November 21, 2023
Via
Benzinga
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update
November 21, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer
November 21, 2023
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Outlook For MediWound
November 20, 2023
Via
Benzinga
MediWound to Report Third Quarter 2023 Financial Results
November 14, 2023
Conference Call and Webcast Scheduled for Tuesday, November 21st at 8:30 am Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
HC Wainwright & Co. Maintains Buy Rating for MediWound: Here's What You Need To Know
September 21, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About MediWound
August 17, 2023
Via
Benzinga
MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients
November 13, 2023
The label expansion will solidify NexoBrid’s position in the EU as a safe and effective non-surgical treatment for burn patients of all ages
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe
November 08, 2023
NexoBrid complements PMI’s portfolio, allowing it to provide a comprehensive solution for burn patients
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Collaboration with 3M on EscharEx® Phase III Study
October 11, 2023
MediWound to join forces with 3M Health Care, world’s largest wound care company in pivotal study for patients with venous leg ulcers
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Outlook For MediWound
August 14, 2023
Via
Benzinga
Recap: MediWound Q1 Earnings
May 30, 2023
Via
Benzinga
Earnings Outlook For MediWound
May 29, 2023
Via
Benzinga
MediWound Deploys NexoBrid® for Emergency Supply
October 09, 2023
From
MediWound Ltd.
Via
GlobeNewswire
Q4 Stock Predictions: 3 Micro-Cap Stocks Ready to Skyrocket Into 2024
October 03, 2023
These Q4 micro-cap stocks are the ones to buy in on for long-term growth and returns to any investor's portfolio.
Via
InvestorPlace
MediWound Announces U.S. Commercial Availability of NexoBrid® for the Treatment of Severe Thermal Burns in Adults
September 21, 2023
Full commercial launch of NexoBrid marks important first step to becoming the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal burns
From
MediWound Ltd.
Via
GlobeNewswire
MediWound’s NexoBrid® Highlighted in 20 Oral and Poster Presentations at the 20th European Burns Association Congress
September 11, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Participate in Fireside Chat at H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update
August 15, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Collaboration with Mölnlycke on EscharEx® Phase III Study
August 15, 2023
MediWound joins forces with one of the largest global chronic wound companies in pivotal study for patients with venous leg ulcers
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study
August 15, 2023
MediWound to join forces with leading chronic wound allograft company in pivotal study for patients with venous leg ulcers
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Second Quarter 2023 Financial Results
August 07, 2023
Conference Call and Webcast Scheduled for Wednesday, August 16th at 8:30 am Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Commercial Launch of NexoBrid® in Japan
August 01, 2023
Kaken Pharmaceutical launches NexoBrid under an exclusive marketing and distribution agreement
From
MediWound Ltd.
Via
GlobeNewswire
3 Micro-Cap Stocks to Buy for Multibagger Returns
July 11, 2023
These are the micro-cap stocks to buy and they represent companies with decent fundamentals and visibility for robust growth.
Via
InvestorPlace
MediWound Announces Positive Results in Its U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
July 10, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Receives Positive Scientific Advice from European Medicine Agency (EMA) on EscharEx Phase III Study Design
July 03, 2023
Affirms the clear path forward for the Company’s global Phase III study of EscharEx in venous leg ulcers
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Participate in Fireside Chat at Maxim Group Healthcare Virtual Conference 2023
June 14, 2023
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Scheduled For May 30, 2023
May 30, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its first quarter.
Via
Benzinga
MediWound Reports First Quarter 2023 Financial Results and Provides a Company Update
May 30, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report First Quarter 2023 Financial Results
May 12, 2023
Conference Call and Webcast Scheduled for Tuesday, May 30th at 8:30 am Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.